Clinical Trials Browser

Adenocarcinoma, Neoplasms, Stomach Neoplasms

Breast Neoplasms, Meningeal Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Pancreatic Neoplasms

Rectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Stomach Neoplasms

Pancreatic Neoplasms

Colorectal Neoplasms

Melanoma, Neoplasm Metastasis, Sarcoma

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

Pancreatic Neoplasms

Triple Negative Breast Neoplasms

Carcinoma, Squamous Cell

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Pancreatic Neoplasms

Rectal Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms, Colorectal Neoplasms

Breast Neoplasms

Rectal Neoplasms

Breast Neoplasms

Squamous Cell Carcinoma of Head and Neck

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Stomach Neoplasms, Colorectal Neoplasms

Pituitary Neoplasms

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Turcot syndrome, Colorectal Neoplasms

Rectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Breast Neoplasms

Breast Neoplasms

Pancreatic Neoplasms

Carcinoma, Hepatocellular, Liver Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Neoplasm Metastasis, Rectal Neoplasms

Breast Neoplasms, Stomach Neoplasms

Rectal Neoplasms, Colorectal Neoplasms

Gastrointestinal Neoplasms

Solid Tumors

Breast Neoplasms

Stomach Neoplasms

Pancreatic Neoplasms

Breast Neoplasms, Diarrhea, Neoplasms

Breast Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Breast Neoplasms

Esophageal Neoplasms, Stomach Neoplasms

Clinical Trials

DisTinGuish

Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD

PERSEVERE

Lapatinib and Capecitabine for Second Line Treatment of Pancreas Cancer

Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer

Sunitinib and Capecitabine for First Line Colon Cancer

Nintedanib Alone or in Combination With Capecitabine in Refractory Metastatic Colorectal Cancer [LUME-Colon 2]

FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer

QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy

QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine

MODULATE

A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer

Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy

QUILT-3.080: NANT Pancreatic Cancer Vaccine

QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.

QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed

HIGH-LIGHT

QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy

Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer

QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy

Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma

Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer

Radiation Therapy and Capecitabine With or Without Curcumin Before Surgery in Treating Patients With Rectal Cancer

Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

Docetaxel and Capecitabine With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Cancers

TMZ-Cap

Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab

Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004

A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotherapy in Locally Advanced Adenocarcinoma of the Rectum

Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon

Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From China

A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer

Chemotherapy Plus Proton-chemotherapy for Locally Advanced Pancreatic Cancer

Sorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma

Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

BrUOG 302:BYL719, Capecitabine and Radiation for Rectal Cancer: A Brown University Oncology Research Group Study

TRAXHER2

Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer

GABLE

A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols

Enzastaurin in Combination of Capecitabine to Treat Breast Cancer

Phase II Study of Ramucirumab With Chemotherapy in Patients With Metastatic Gastroesophageal Junction and Gastric Cancer

Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer

Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse

Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1)

Individualized Drug Treatment for Treating Patients With Pancreatic Cancer

Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular Characteristics

mEGA